# OnCo record nct04954001 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04954001/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04954001", "NCT04954001" ;
  schema:name "Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1"@en ;
  schema:description "A phase 1/2 trial of FCN-159 in childhood cancers, run by Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04954001/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04954001> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2021-03-26" ;
  onco:cancers <https://onco.cc/cancers/childhood-cancers/> ;
  onco:companies <https://onco.cc/companies/shanghai-fosun-pharmaceutical-industrial-development/> .